(WASHINGTON) -- Moderna announced Thursday that it's launched early-stage clinical trials of an HIV mRNA vaccine. The biotechnology company has teamed up with the nonprofit International AIDS Vaccine Initiative to develop the shot, which uses the same technology as Moderna's successful COVID-19 vaccine. The first participants... Read More.
(NEW YORK) -- The U.S. Food and Drug Administration (FDA) has approved the first-ever long-acting injectable drug for HIV prevention. Until this week, the only FDA-licensed and approved medications for HIV pre-exposure prophylaxis, most commonly known as PrEP, were daily oral pills containing the HIV... Read More.
(ATLANTA) -- While a cure for HIV has remained elusive, in recent years there have been great strides made in the prevention and management of HIV and AIDS, the disease the virus causes if left untreated. Now, the Centers for Disease Control and Prevention wants... Read More.
(LONDON) -- The UK approved a new HIV treatment that requires an injection every other month, rather than the current routine of taking pills every day. The UK's National Institute for Health and Care Excellence estimated that around 13,000 people will now be eligible for... Read More.
(NEW YORK) -- In yet another setback in the decadeslong scientific quest for an HIV vaccine, a Johnson & Johnson HIV vaccine candidate failed to reduce the risk of infection in a clinical trial among women in southern Africa. The would-be vaccine uses the same... Read More.
(NEW YORK) -- While COVID-19 raged in the United States, a set of public health crises was pushed to the background. HIV and drug use flourished during the pandemic, fueled in part by extended isolation and economic fallout. Relapses were commonplace and services harder to access.... Read More.
(LA JOLLA, Calif.) -- After more than 30 years of attempts, there may be a promising advance in the search for a vaccine for HIV, the virus that causes AIDS if left untreated. Now, preliminary data from an early stage clinical trial out of the... Read More.
By DR. TARUN JAIN, ABC News (NEW YORK) -- The COVID-19 pandemic may be leading to decreased HIV testing and care, according to several new studies discussed at the Conference on Retroviruses and Opportunistic Infections, a medical conference held virtually this week.
By DR. DIVYA CHHABRA, ABC News (NEW YORK) -- Marc Wagner is a researcher and activist who has been living with HIV for 35 years. He is one of hundreds of HIV-positive people participating in clinical trials for COVID-19 vaccines."I'm glad... Read More.